A family history of colorectal cancer (CRC) increases CRC incidence similarly in patients with inflammatory bowel disease (IBD) and matched comparators from the general population, according to a ...

Studies presented at the Society of Hematologic Oncology 2026 Annual Meeting will inform treatment strategies in acute ...

In this phase 2 study, researchers assessed the feasibility and efficacy of a response-adapted surgical strategy in patients with LA-HNSCC who achieved major tumor regression after neoadjuvant ...

In this analysis, researchers sought to understand perceived risk for sexual dysfunction among male survivors of childhood cancer and to examine how and when survivors received information on sexual ...

The addition of local consolidation therapy to ipilimumab plus nivolumab numerically shortens survival in stage IV non-small ...

The most impactful findings on AML from the European Hematology Association 2026 Congress are highlighted in this research ...

Investigators reported initial results from the VAPOR 2 study, which assessed partial gland water vapor ablation in men with grade group 2 prostate cancer.

Nurse practitioners, physician associates, and advanced practice registered nurses can now independently order noninvasive colorectal cancer screenings for Medicare patients.

Pumitamig+elfe-D demonstrated encouraging early efficacy with a manageable safety profile for patients with SCLC.

In this extended follow-up from the phase 3 KEYNOTE-826 trial, researchers reported on 5-year outcomes of pembrolizumab and chemotherapy in cervical cancer.

Researchers aimed to determine how spending for prostate cancer-related health care changed from 2012 to 2021, and which components of care accounted for these changes.

A multidisciplinary panel created a competency model to address the expanding demands of genomic technologies on the cancer care workforce.